{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11096013",
  "DateCompleted": {
    "Year": "2001",
    "Month": "04",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "12",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2000",
        "Month": "11",
        "Day": "29"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1058-4838",
      "JournalIssue": {
        "Volume": "31",
        "Issue": "6",
        "PubDate": {
          "Year": "2000",
          "Month": "Dec"
        }
      },
      "Title": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
      "ISOAbbreviation": "Clin Infect Dis"
    },
    "ArticleTitle": "Novelties in the field of anti-infective compounds in 1999.",
    "Pagination": {
      "StartPage": "1423",
      "EndPage": "1466",
      "MedlinePgn": "1423-66"
    },
    "Abstract": {
      "AbstractText": [
        "In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reported in the field of anti-infectives for gram-negative bacteria. At the moment, we are in a period of discovery as we await novel compounds that could issue from new engineering."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Aventis Pharma, Infectious Disease Group, Romainville, France. andre.bryskier@aventis.com"
          }
        ],
        "LastName": "Bryskier",
        "ForeName": "A",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Infect Dis",
    "NlmUniqueID": "9203213",
    "ISSNLinking": "1058-4838"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Drugs, Investigational"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "chemistry",
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Bacteria"
    },
    {
      "QualifierName": [
        "chemistry",
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Drugs, Investigational"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Eukaryota"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Infections"
    }
  ],
  "NumberOfReferences": "210"
}